BioCentury
ARTICLE | Company News

Dara BioSciences sales and marketing update

May 19, 2014 7:00 AM UTC

Dara launched its "No Coupon, No Co-pay, No Hassles" retail patient saving program for Gelclair povidone for oral mucositis and Soltamox tamoxifen for breast cancer. The program will apply to all qualified prescriptions, providing the majority of patients with a $0 out-of-pocket cost for both drugs. Gelclair is a bioadherent oral gel, and Soltamox is a liquid formulation of tamoxifen citrate, an off-patent selective estrogen receptor modulator (SERM). ...